Theratechnologies Stock Analysis

Theratechnologies Stock Analysis Notes

About 52.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.04. Theratechnologies had not issued any dividends in recent years. The entity had 1:4 split on the 31st of July 2023. Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company was incorporated in 1993 and is headquartered in Montreal, Canada. Theratechnologies operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 87 people. To find out more about Theratechnologies contact Paul Lvesque at 514 336 7800 or learn more at https://www.theratech.com.

Theratechnologies Investment Alerts

Theratechnologies Upcoming and Recent Events

Theratechnologies Largest EPS Surprises

View All Earnings Estimates

Theratechnologies Stock Institutional Investors

Note, although Theratechnologies' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Theratechnologies Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 55.72 M.

Theratechnologies Profitablity

The company has Profit Margin (PM) of (0.04) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.27 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.27.

Management Efficiency

Theratechnologies has return on total asset (ROA) of 0.1176 % which means that it generated a profit of $0.1176 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.1686) %, meaning that it created substantial loss on money invested by shareholders. Theratechnologies' management efficiency ratios could be used to measure how well Theratechnologies manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to rise to 1.39 in 2024, whereas Return On Tangible Assets are likely to drop (0.44) in 2024. At this time, Theratechnologies' Non Current Assets Total are fairly stable compared to the past year. Other Assets is likely to rise to about 2.2 M in 2024, whereas Total Assets are likely to drop slightly above 65.2 M in 2024.

Technical Drivers

As of the 2nd of December, Theratechnologies has the insignificant Risk Adjusted Performance, variance of 10.19, and Coefficient Of Variation of (6,911). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Theratechnologies, as well as the relationship between them.

Theratechnologies Price Movement Analysis

Theratechnologies Outstanding Bonds

Theratechnologies Predictive Daily Indicators

Theratechnologies Forecast Models

Theratechnologies' time-series forecasting models are one of many Theratechnologies' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Theratechnologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Theratechnologies prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Theratechnologies shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Theratechnologies. By using and applying Theratechnologies Stock analysis, traders can create a robust methodology for identifying Theratechnologies entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Theratechnologies analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Theratechnologies analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Theratechnologies stock analysis indicators help investors evaluate how Theratechnologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Theratechnologies shares will generate the highest return on investment. By understating and applying Theratechnologies stock analysis, traders can identify Theratechnologies position entry and exit signals to maximize returns.

When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.